PTC THERAPEUTICS INC - UNAUDITED 2025 TOTAL PRODUCT AND ROYALTY REVENUE OF APPROXIMATELY $823M, EXCEEDING GUIDANCE
PTC THERAPEUTICS INC - SEPHIENCE LAUNCH CONTINUES WITH UNAUDITED Q4 GLOBAL REVENUE OF $92.5M
Source text: ID:nPn6xgw3sa
Further company coverage: PTCT.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.